Lek announces more focus on innovative drugs
Ljubljana, 5 February - Addressing the press on Wednesday amid continuing speculation about the plans of Novartis, representatives of the Swiss multinational's Slovenian subsidiary Lek said Novartis would continue a reform in Slovenia that included the transformation of production locations and more focus on innovative drugs along with generics.
The rest of this news item is available to subscribers.
The news item consists of 1.662 characters (without spaces) or 315 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.